Endothelial contractile cytoskeleton and microvascular permeability

References

• Feng D, Nagy JA, Hipp J, et al. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med. 1996;183:1981–1986.
   PubMed Web of Science ®Google Scholar
• Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev. 2006;86:279–367.
   PubMed Web of Science ®Google Scholar
• Lewalle JM. Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro. Exp Cell Res. 1997;237:347–356.
   PubMed Web of Science ®Google Scholar
• Iyer S, Ferreri DM, DeCocco NC, et al. VE-cadherin-p120 interaction is required for maintenance of endothelial barrier function. Am J Physiol Lung Cell Mol Physiol. 2004;286:L1143–L1153.
   PubMed Web of Science ®Google Scholar
• Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol. 2001;91:1487–1500.
   PubMed Web of Science ®Google Scholar
• Wu MH. Endothelial focal adhesions and barrier function. J Physiol. 2005;569:359–366.
   PubMed Web of Science ®Google Scholar
• Playford MP, Schaller, MD. The interplay between Src and integrins in normal and tumor biology. Oncogene. 2004;23:7928–7946.
   PubMed Web of Science ®Google Scholar
• Prasain N, Stevens T. The actin cytoskeleton in endothelial cell phenotypes. Microvasc Res. 2009;77:53–63.
   PubMed Web of Science ®Google Scholar
• Tiruppathi C, Ahmmed GU, Vogel SM, et al. Ca2+ signaling, TRP channels, and endothelial permeability. Microcirculation. 2006;13:693–708.
   PubMed Web of Science ®Google Scholar
• Carlier MF, Pantaloni D. Control of actin dynamics in cell motility. J Mol Biol. 1997;269:459–467.
   Web of Science ®Google Scholar
• Bindschadler M, McGrath JL. Relationships between actin regulatory mechanisms and measurable state variables. Ann Biomed Eng. 2007;35:995–1011.
   Web of Science ®Google Scholar
• Perelroizen I, Didry D, Christensen H, et al. Role of nucleotide exchange and hydrolysis in the function of profilin in action assembly. J Biol Chem. 1996;271:12302–12309.
   Web of Science ®Google Scholar
• Goldschmidt-Clermont PJ, Kim JW, Machesky LM, et al. Regulation of phospholipase C-gamma 1 by profilin and tyrosine phosphorylation. Science. 1991;251:1231–1233.
   PubMed Web of Science ®Google Scholar
• Yu FX, Sun HQ, Janmey PA, et al. Identification of a polyphosphoinositide-binding sequence in an actin monomerbinding domain of gelsolin. J Biol Chem. 1992;267:14616–14621.
   PubMed Web of Science ®Google Scholar
• van Rheenen J. EGF-induced PIP2 hydrolysis releases and activates cofilin locally in carcinoma cells. J Cell Biol. 2007;179:1247–1259.
   Web of Science ®Google Scholar
• Welch MD, Mullins RD. Cellular control of actin nucleation. Annu Rev Cell Dev Biol. 2002;18:247–288.
   PubMed Web of Science ®Google Scholar
• Raftopoulou M, Hall A. Cell migration: Rho GTPases lead the way. Dev Biol. 2004;265:23–32.
   PubMed Web of Science ®Google Scholar
• Garcia JG, Davis HW, Patterson CE. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol. 1995;163:510–522.
   PubMed Web of Science ®Google Scholar
• Goeckeler ZM, Wysolmerski RB. Myosin light chain kinase-regulated endothelial cell contraction: the relationship between isometric tension, actin polymerization, and myosin phosphorylation. J Cell Biol. 1995;130:613–627.
   PubMed Web of Science ®Google Scholar
• Hixenbaugh EA. Stimulated neutrophils induce myosin light chain phosphorylation and isometric tension in endothelial cells. Am J Physiol. 1997;273:H981–H988.
   Google Scholar
• Verin AD, Gilbert-McClain LI, Patterson CE, et al. Biochemical regulation of the nonmuscle myosin light chain kinase isoform in bovine endothelium. Am J Respir Cell Mol Biol. 1998;19:767–776.
   PubMed Web of Science ®Google Scholar
• Verin AD, Patterson CE, Day MA, et al. Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. Am J Physiol. 1995;269:L99–L108.
   PubMed Web of Science ®Google Scholar
• Hall A. Rho GTPases and the actin cytoskeleton. Science. 1998:279:509–514.
   Web of Science ®Google Scholar
• Totsukawa G. Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J Cell Biol. 2000;150:797–806.
   PubMed Web of Science ®Google Scholar
• Essler M. Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells. J Biol Chem. 1998;273:21867–21874.
   PubMed Web of Science ®Google Scholar
• Essler M. Mildly oxidized low density lipoprotein induces contraction of human endothelial cells through activation of Rho/Rho kinase and inhibition of myosin light chain phosphatase. J Biol Chem. 1999;274:30361–30364.
   PubMed Web of Science ®Google Scholar
• Amano M. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem. 1996;271:20246–20249.
   PubMed Web of Science ®Google Scholar
• Mehta D. RhoA interaction with inositol 1,4,5-trisphosphate receptor and transient receptor potential channel-1 regulates Ca2+ entry. Role in signaling increased endothelial permeability. J Biol Chem. 2003;278:33492–33500.
   PubMed Web of Science ®Google Scholar
• Sanchez T. Induction of vascular permeability by the sphingosine-1- phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arterioscler Thromb Vasc Biol. 2007;27:1312–1318.
   PubMed Web of Science ®Google Scholar
• Yuan SY. Protein kinase signaling in the modulation of microvascular permeability. Vascul Pharmacol. 2002;39:213–223.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Huang Q, Wu HM. Myosin light chain phosphorylation: modulation of basal and agonist-stimulated venular permeability. Am J Physiol. 1997;272:H1437–H1443.
   PubMed Web of Science ®Google Scholar
• Moy AB, Shasby SS, Scott BD, et al. The effect of histamine and cyclic adenosine monophosphate on myosin light chain phosphorylation in human umbilical vein endothelial cells. J Clin Invest. 1993;92:1198–1206.
   PubMed Web of Science ®Google Scholar
• Morel NM, Petruzzo PP, Hechtman HB, et al. Inflammatory agonists that increase microvascular permeability in vivo stimulate cultured pulmonary microvessel endothelial cell contraction. Inflammation. 1990;14:571–583.
   PubMed Web of Science ®Google Scholar
• Tinsley JH, De Lanerolle P, Wilson E, et al. Myosin light chain kinase transference induces myosin light chain activation and endothelial hyperpermeability. Am J Physiol Cell Physiol. 2000;279: C1285–1289.
   Web of Science ®Google Scholar
• Cioffi WG. What’s new in burns and metabolism. J Am Coll Surg. 2001;192:241–254.
   Web of Science ®Google Scholar
• Lund T, Onarheim H, Reed RK. Pathogenesis of edema formation in burn injuries. World J Surg. 1992;16:2–9.
   Web of Science ®Google Scholar
• Gibran NS, Heimbach DM. Current status of burn wound pathophysiology. Clin Plast Surg. 2000;27:11–22.
   PubMed Web of Science ®Google Scholar
• Tinsley JH, Teasdale NR, Yuan SY. Myosin light chain phosphorylation and pulmonary endothelial cell hyperpermeability in burns. Am J Physiol Lung Cell Mol Physiol. 2004;286:L841–L847.
   Web of Science ®Google Scholar
• Huang Q, Xu WJ, Ustinova EE, et al. Myosin light chain kinase- dependent microvascular hyperpermeability in thermal injury. Shock. 2003;20:363–368.
   Web of Science ®Google Scholar
• Gibran NS, Heimbach DM. Mediators in thermal injury. Semin Nephrol. 1993;13:344–358.
   Web of Science ®Google Scholar
• Kowal-Vern A, Walenga JM, Sharp-Pucci M, et al. Postburn edema and related changes in interleukin-2, leukocytes, platelet activation, endothelin-1, and C1 esterase inhibitor. J Burn Care Rehabil. 1997;18:99–103.
   Google Scholar
• Kurose I, Wolf R, Miyasaka M, et al. Microvascular dysfunction induced by nonsteroidal anti-inflammatory drugs: role of leukocytes. Am J Physiol. 1996;270:G363–G369.
   Google Scholar
• Wainwright MS. Protein kinase involved in lung injury susceptibility: evidence from enzyme isoform genetic knockout and in vivo inhibitor treatment. Proc Natl Acad Sci U S A. 2003;100:6233–6238.
   Web of Science ®Google Scholar
• Behanna HA, Watterson DM, Ranaivo HR. Development of a novel bio- available inhibitor of the calmodulin-regulated protein kinase MLCK: a lead compound that attenuates vascular leak. Biochim Biophys Acta. 2006;1763:1266–1274.
   Web of Science ®Google Scholar
• Reynoso R, Perrin RM, Breslin JW, et al. A role for long chain myosin light chain kinase (MLCK-210) in microvascular hyperpermeability during severe burns. Shock. 2007;28:589–595.
   Web of Science ®Google Scholar
• Yuan SY, Wu MH, Ustinova EE, et al. Myosin light chain phosphorylation in neutrophil-stimulated coronary microvascular leakage. Circ Res. 2002;90:1214–1221.
   PubMed Web of Science ®Google Scholar
• Breslin JW, Yuan SY. Involvement of RhoA and Rho kinase in neutrophil-stimulated endothelial hyperpermeability. Am J Physiol Heart Circ Physiol. 2004;286:H1057–H1062.
   Web of Science ®Google Scholar
• Breslin JW, Sun H, Xu WJ, et al. Involvement of ROCK-mediated endothelial tension development in neutrophil-stimulated microvascular leakage. Am J Physiol Heart Circ Physiol. 2006;290:H741–H750.
   Web of Science ®Google Scholar
• Abumiya T, Yokota C, Kuge Y, et al. Aggravation of hemorrhagic transformation by early intraarterial infusion of low-dose vascular endothelial growth factor after transient focal cerebral ischemia in rats. Brain Res. 2005;1049:95–103.
   PubMed Web of Science ®Google Scholar
• Godzich M. Activation of the stress protein response prevents the development of pulmonary edema by inhibiting VEGF cell signaling in a model of lung ischemia-reperfusion injury in rats. Faseb J. 2006;20:1519–1521.
   Web of Science ®Google Scholar
• Caldwell RB. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug Targets. 2005;6:511–524.
   PubMed Web of Science ®Google Scholar
• Wu HM, Huang Q, Yuan Y, et al. VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol. 1996;271: H2735-H2739.
   Google Scholar
• Wu HM, Yuan Y, Zawieja DC, et al. Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability. Am J Physiol. 1999;276:H535–H542.
   Google Scholar
• Wu MH, Yuan SY, Granger HJ. The protein kinase MEK1/2 mediate vascular endothelial growth factor- and histamine-induced hyperpermeability in porcine coronary venules. J Physiol. 2005;563:95–104.
   PubMed Web of Science ®Google Scholar
• Leung T, Chen XQ, Manser E, et al. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol. 1996;16:5313–5327.
   PubMed Web of Science ®Google Scholar
• Sun H, Breslin JW, Zhu J, et al. Rho and ROCK signaling in VEGF- induced microvascular endothelial hyperpermeability. Microcirculation. 2006;13:237–247.
   PubMed Web of Science ®Google Scholar
• Barakat MR, Kaiser PK. VEGF inhibitors for the treatment of neovas- cular age-related macular degeneration. Expert Opin Investig Drugs. 2009;18:637–646.
   PubMed Web of Science ®Google Scholar
• Lee FY. Synergistic antitumor activity of ixabepilone (BMS-247550) plus bevacizumab in multiple in vivo tumor models. Clin Cancer Res. 2008;14:8123–8131.
   Google Scholar
• Gerber HP, Kowalski J, Sherman D, et al. Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor. Cancer Res. 2000;60:6253–6258.
   PubMed Web of Science ®Google Scholar
• Zhang J. Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors. Cancer. 2007;109:1478–1486.
   PubMed Web of Science ®Google Scholar
• Saigo M, Hsue PY, Waters DD. Role of thrombotic and fibrinolytic factors in acute coronary syndromes. Prog Cardiovasc Dis. 2004;46:524–538.
   Web of Science ®Google Scholar
• Zacharowski K, Zacharowski P, Reingruber S, et al. Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction. J Mol Med. 2006;84:469–477.
   PubMed Web of Science ®Google Scholar
• Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005;3:1894–1904.
   PubMed Web of Science ®Google Scholar
• Doolittle RF. Determining the crystal structure of fibrinogen. J Thromb Haemost. 2004;2:683–689.
   Web of Science ®Google Scholar
• Lord ST. Fibrinogen and fibrin: scaffold proteins in hemostasis. Curr Opin Hematol. 2007;14:236–241.
   PubMed Web of Science ®Google Scholar
• Tyagi N, Roberts AM, Dean WL, et al. Fibrinogen induces endothelial cell permeability. Mol Cell Biochem. 2008;307:13–22.
   PubMed Web of Science ®Google Scholar
• Allard MF, Doerschuk CM, Brumwell ML, et al. Oleic acid-induced lung injury in rabbits: effect of fibrinogen depletion with Arvin. J Appl Physiol. 1988;64:920–928.
   Web of Science ®Google Scholar
• Ge M, Ryan TJ, Lum H, et al. Fibrinogen degradation product fragment D increases endothelial monolayer permeability. Am J Physiol. 1991;261:L283–L289.
   Google Scholar
• Lo SK, Del Vecchio PJ, Lum H, et al. Fibrin contact increases endothelial permeability to albumin. J Cell Physiol. 1992;151:63–70.
   Web of Science ®Google Scholar
• Guo M, Daines D, Tang J, et al. Fibrinogen-gamma C-terminal fragments induce endothelial barrier dysfunction and microvascular leak via integrin-mediated and RhoA-dependent mechanism. Arterioscler Thromb Vasc Biol. 2009;29:394–400.
   PubMed Web of Science ®Google Scholar
• Chiba Y, Ishii Y, Kitamura S, et al. Activation of rho is involved in the mechanism of hydrogen-peroxide-induced lung edema in isolated perfused rabbit lung. Microvasc Res. 2001;62:164–171.
   Web of Science ®Google Scholar
• Koksel O. Rho-kinase (ROCK-1 and ROCK-2) upregulation in oleic acid-induced lung injury and its restoration by Y-27632. Eur J Pharmacol. 2005;510:135–142.
   Web of Science ®Google Scholar
• Arita R. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage. Diabetes. 2009;58:215–226.
   PubMed Web of Science ®Google Scholar
• Peng F. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease. Diabetes. 2008;57:1683–1692.
   PubMed Web of Science ®Google Scholar